Opinion: Canada is long overdue for a national registry of drug company payments to doctors

It is past time for Canada to create a national registry of payments that pharmaceutical and medical device companies make to health care providers.

Ontario recently took a historic step as the first province in Canada to introduce legislation that would shine a light on interactions between drug companies and prescribers. The use of the term “historic” here is not hyperbole, since the extent of payments by the pharmaceutical industry to individual physicians in Canada has never been known.

Other countries, such as the United States and France, have been making such information public for a few years now. But Ontario’s bill would provide a wider scope of transparency by including

You're reading a preview, sign up to read more.

More from STAT

STAT5 min readWellness
What The Ebola Emergency Means, What It Doesn’t Mean, And What’s Next
Finally, the WHO has declared the world’s latest Ebola outbreak a global health emergency. But what, exactly, does that mean?
STAT7 min readPsychology
Do Elon Musk’s Brain-decoding Implants Have Potential? Experts Say They Just Might
Do Elon Musk’s brain-decoding implants have potential? Independent experts consulted by STAT say they very well might.
STAT3 min read
Opinion: I Get Asked A Lot About Longevity. It Helps That I’m 104
As scientists pursue longevity and anti-aging research, we wanted to hear from a centenarian on her life experience and thoughts on aging. So we called one.